CRYSTALLINE FORM OF 1-(1-OXO-1,2-DIHYDROISOQUINOLINE-5-YL)-5-(TRIFLUOROMETHYL)-(2-(TRIFLUOROMETHYL)PYRIDIN-4-YL)-1H-PYRAZOLE-4-CARBOXAMIDE MONOHYDRATE
MA55019AUndetermined Publication Date: 2021-12-29JANSSEN PHARMA NV
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MA55019
- Authority / Receiving Office
- MA · MA
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2019-02-22
- Filing Date
- 2020-02-20
- Publication Date
- 2021-12-29
Need to check novelty before this filing date? Find Prior Art
No text content released.